Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-4-25
pubmed:databankReference
pubmed:abstractText
The new beta-lactamase SHV-72 was isolated from clinical Klebsiella pneumoniae INSRA1229, which exhibited the unusual association of resistance to the amoxicillin-clavulanic acid combination (MIC, 64 microg/ml) and susceptibility to cephalosporins, aztreonam, and imipenem. SHV-72 (pI 7.6) harbored the three amino acid substitutions Ile8Phe, Ala146Val, and Lys234Arg. SHV-72 had high catalytic efficiency against penicillins (k(cat)/K(m), 35 to 287 microM(-1) x s(-1)) and no activity against oxyimino beta-lactams. The concentration of clavulanic acid necessary to inhibit the enzyme activity by 50% was 10-fold higher for SHV-72 than for SHV-1. Molecular-dynamics simulation suggested that the Lys234Arg substitution in SHV-72 stabilized an atypical conformation of the Ser130 side chain, which moved the O gamma atom of Ser130 around 3.5 A away from the key O gamma atom of the reactive serine (Ser70). This movement may therefore decrease the susceptibility to clavulanic acid by preventing cross-linking between Ser130 and Ser70.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-10231522, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-10350372, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-10991849, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-11036023, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-11148033, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-11451684, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-11502506, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-11585791, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-11890794, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-11996574, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-12058046, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-12543688, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-12937001, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-14534312, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-15504885, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-15518561, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-15826180, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-15981999, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-15987690, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-16436733, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-16803899, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-16938422, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-1910040, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-4198636, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-6109327, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-7574506, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-7727028, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-8665470, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-8744570, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-9087500, http://linkedlifedata.com/resource/pubmed/commentcorrection/18316518-9736532
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1098-6596
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
52
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1806-11
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:18316518-Amino Acid Substitution, pubmed-meshheading:18316518-Amoxicillin, pubmed-meshheading:18316518-Anti-Bacterial Agents, pubmed-meshheading:18316518-Arginine, pubmed-meshheading:18316518-Aztreonam, pubmed-meshheading:18316518-Bacterial Proteins, pubmed-meshheading:18316518-Cephalosporins, pubmed-meshheading:18316518-Clavulanic Acid, pubmed-meshheading:18316518-Computer Simulation, pubmed-meshheading:18316518-Imipenem, pubmed-meshheading:18316518-Isoelectric Focusing, pubmed-meshheading:18316518-Kinetics, pubmed-meshheading:18316518-Klebsiella pneumoniae, pubmed-meshheading:18316518-Lysine, pubmed-meshheading:18316518-Microbial Sensitivity Tests, pubmed-meshheading:18316518-Models, Molecular, pubmed-meshheading:18316518-Molecular Sequence Data, pubmed-meshheading:18316518-Penicillins, pubmed-meshheading:18316518-Protein Conformation, pubmed-meshheading:18316518-Protein Structure, Tertiary, pubmed-meshheading:18316518-beta-Lactamases
pubmed:year
2008
pubmed:articleTitle
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
pubmed:affiliation
Antibiotic Resistance Unit, Department of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge Av. Padre Cruz, 1649-016 Lisbon, Portugal.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't